All companies
Visit website
EPI ONE
OperatingEpi One Inc.
Healthcare · Founded 2016
Accurate, Affordable early cancer detection
Post-money valuation ⓘ
$48.3M
As of Dec 2024 · from Epi One Common Stock 2 · pre-money + amount raised, not a traded price
Total raised
$2,984,944
Across 2 rounds since 2024
Latest share price
$7.28
Epi One Common Stock 2 offering price
Financials
FY2022–FY2025 · from SEC filings · hover any figure for its source$0
−$40K
2022
$0
−$50K
2023
$0
−$970K
2024
$0
−$1.0M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
-$40,151
-$49,920
-$969,713
-$1,026,374
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$78,180
$56,854
$2,598,462
$1,548,540
Accounts receivable
$0
$0
$0
$0
Total assets
$78,500
$215,010
$2,994,951
$2,102,409
Short-term debt
$2,261
$45,568
$1,494
$19,426
Long-term debt
$0
$0
$0
$0
Total liabilities
$2,261
$45,568
$1,494
$19,426
Other
Headcount
—
3
4
4
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$46.1M
post-money
$48.3M
post-money
Epi One Class B Common Stock 1
Epi One Common Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $1.9M / $3.8MInvestors 458Post-money $48.3M
Raised $1.1M / $5MInvestors 205Post-money $46.1M
Reg CF annual-report compliance
Compliant
Filed 2 of 2 annual reports (FY2024–FY2025)
458 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0002018216Share price $7.28
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.